Prosecution Insights
Prosecution Insights
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSELEY II, NELSON B | 1 | 68.0% | +41.2% |
| BUNNER, BRIDGET E | 1 | 64.2% | +19.8% |
| STONEBRAKER, ALYSSA RAE | 1 | 55.8% | +48.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18182308 | CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF | MOSELEY II, NELSON B | — |
| 17923208 | APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS WITH AND WITHOUT A T CELL INHIBITORY PROTEIN AND METHODS OF USE THEREOF | BUNNER, BRIDGET E | — |
| 17603827 | METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINS | STONEBRAKER, ALYSSA RAE | — |
| Art Unit | Apps |
|---|---|
| 1642 | 2 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18182308 | CD80 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF | MOSELEY II, NELSON B | 1642 | DP | Non-Final OA | — | Pending | Mar 10, 2023 |
| 17923208 | APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS WITH AND WITHOUT A T CELL INHIBITORY PROTEIN AND METHODS OF USE THEREOF | BUNNER, BRIDGET E | 1647 | DP | Non-Final OA | — | Pending | Nov 03, 2022 |
| 17603827 | METHODS AND USES OF VARIANT ICOS LIGAND (ICOSL) FUSION PROTEINS | STONEBRAKER, ALYSSA RAE | 1642 | DP | Non-Final OA | — | Pending | Oct 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial